QART Medical, founded by Prof Natan Shaked finalizes round of venture investment

QART (Quantitative Assisted Reproductive Technologies) Medical, a clinical-stage MedTech company, addressing the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF), aiming to create a new and better gold standard in the ART market.  The QART system aims to improve current success rates of Intra-Cytoplasmic Sperm Injection 

Prof. Natan T. Shaked is associate Professor in the Department of Biomedical Engineering at Tel Aviv University. Between April 2011-July 2015, he was a Senior Lecturer (Assistant Professor) in the same department. Previously, Prof. Shaked was a Visiting Assistant Professor in the Department of Biomedical Engineering at Duke University, Durham, North Carolina, USA. Prof. Shaked heads the Biomedical Optical Microscopy, Nanoscopy and Interferometry Research Group, a large experimental group performing a multidisciplinary research involving optical engineering, imaging and sensing in biological systems, optical therapy, and biophysics. Specific interests of research include: biomedical optical microscopy and nanoscopy, optical interferometric systems (including interferometric phase microscopy and optical coherence tomography), optical imaging and therapy using nano-particles in biological cells, optical signatures of cancer and fertility problems, and three-dimensional optical imaging and holography for biomedical applications.

Read more